| 发明名称 |
Terazosin transdermal device and methods |
| 摘要 |
A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.
|
| 申请公布号 |
US2005064022(A1) |
申请公布日期 |
2005.03.24 |
| 申请号 |
US20020493002 |
申请日期 |
2002.10.23 |
| 申请人 |
TAVARES LINO;SHEVCHUK IHOR;ALFONSO MARK;MARCENYAC GERALDINE;VALIA KIRTI H. |
发明人 |
TAVARES LINO;SHEVCHUK IHOR;ALFONSO MARK;MARCENYAC GERALDINE;VALIA KIRTI H. |
| 分类号 |
A61K9/70;A61K31/138;A61K31/517;(IPC1-7):A61K9/70 |
主分类号 |
A61K9/70 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
